T2 Biosystems (NASDAQ:TTOO) Earns Sell Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research note published on Saturday morning. The brokerage issued a sell rating on the medical equipment provider’s stock.

T2 Biosystems Trading Down 39.8 %

T2 Biosystems stock opened at $0.11 on Friday. T2 Biosystems has a 12-month low of $0.06 and a 12-month high of $6.80. The firm’s fifty day moving average is $0.27 and its 200 day moving average is $1.23.

T2 Biosystems Company Profile

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.